Journal articles on the topic 'Pharmaceutical industry organizations'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pharmaceutical industry organizations.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Dewan, Azmal Hossain, Chandra Roy Saykat, and Sajadul Huque Mim MD. "Current Scenario of Financial Soundness of Textile, Pharmaceutical and Chemical Industry of Bangladesh: An Emphasize on Altman's Z-Score for Publicly Traded Manufacturing Companies." International Journal of Science and Business 4, no. 4 (2020): 16–34. https://doi.org/10.5281/zenodo.3723187.
Full textKlishchenko, M. Y., and D. A. Kuznetsov. "RESULTS OF THE STUDY OF THREATS TO THE PERSONNEL SECURITY OF PHARMACEUTICAL ORGANIZATIONS." Modern organization of drug supply 9, no. 1 (2022): 28–35. http://dx.doi.org/10.30809/solo.1.2022.3.
Full textGraham, John. "Factors influencing the creation of an industry 4.0 strategy in the generic pharmaceutical industry." Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 20, no. 1 (2024): 28–46. http://dx.doi.org/10.1177/17411343241238178.
Full textMartynov, A. N., and Yu I. Donskova. "THE FINANCIAL AND CREDIT MECHANISM FOR THE DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY AS AN IMPORTANT FACTOR IN STRENGHTENING REGIONAL ECONOMIES: INTERNATIONAL EXPERIENCE." EKONOMIKA I UPRAVLENIE: PROBLEMY, RESHENIYA 8/6, no. 149 (2024): 140–47. http://dx.doi.org/10.36871/ek.up.p.r.2024.08.06.014.
Full textVerma, Y., R. Bansal, N. Gimpaya, M. Scaffidi, R. Khan, and S. Grover. "A99 PHARMACEUTICAL INDUSTRY FUNDING TO GASTROINTESTINAL PATIENT ADVOCACY ORGANIZATIONS." Journal of the Canadian Association of Gastroenterology 5, Supplement_1 (2022): 114–15. http://dx.doi.org/10.1093/jcag/gwab049.098.
Full textArnold, Denis G., and James L. Oakley. "Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials." Journal of Health Politics, Policy and Law 44, no. 5 (2019): 765–87. http://dx.doi.org/10.1215/03616878-7611647.
Full textAdulapuram Aroon, Akuthota Kavya, Mudhadapu Swetha rani, Mandapati Harshitha, and Nagula Anannya. "Evolution of quality assurance in pharmaceutical industry." World Journal of Biology Pharmacy and Health Sciences 20, no. 2 (2024): 656–61. http://dx.doi.org/10.30574/wjbphs.2024.20.2.0937.
Full textSuzuki, Osamu. "How innovators resolve the exploitation-exploration trade-off? Evidence from the Japanese Pharmaceutical Industry." Journal of Innovation Management 2, no. 1 (2014): 47–68. http://dx.doi.org/10.24840/2183-0606_002.001_0005.
Full textV., Sasirekha. "ETHICALLY PRACTICED UNETHICAL STRATEGIES IN PHARMA INDUSTRY - WHOM TO BE BLAMED." International Journal of Research - Granthaalayah 6, no. 2 (2018): 32–45. https://doi.org/10.5281/zenodo.1186096.
Full textBidarova, F. N., B. S. Bidarov, and O. M. Kostyuchenko. "Trends in implementation of good practices in pharmaceutical organizations." Bulletin of the Russian Military Medical Academy 22, no. 1 (2020): 152–57. http://dx.doi.org/10.17816/brmma25985.
Full textSasirekha, V. "ETHICALLY PRACTICED UNETHICAL STRATEGIES IN PHARMA INDUSTRY - WHOM TO BE BLAMED." International Journal of Research -GRANTHAALAYAH 6, no. 2 (2018): 32–45. http://dx.doi.org/10.29121/granthaalayah.v6.i2.2018.1538.
Full textFabbri, Alice, Swestika Swandari, Edith Lau, Agnes Vitry, and Barbara Mintzes. "Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis." International Journal of Health Services 49, no. 2 (2019): 273–93. http://dx.doi.org/10.1177/0020731418823376.
Full textSharabati, Abdel-Aziz Ahmad. "Green Supply Chain Management and Competitive Advantage of Jordanian Pharmaceutical Industry." Sustainability 13, no. 23 (2021): 13315. http://dx.doi.org/10.3390/su132313315.
Full textPoynton, Aaron Sean. "The Incentive Argument in Pharmaceutical Patent Law." Journal of Global Trade, Ethics and Law 1, no. 4 (2024): 1–23. https://doi.org/10.5281/zenodo.10529407.
Full textAlkunsol, William Hanna, Abdel-Aziz Ahmad Sharabati, Nidal Amin AlSalhi, and Hamza Sultan El-Tamimi. "Lean Six Sigma effect on Jordanian pharmaceutical industry’s performance." International Journal of Lean Six Sigma 10, no. 1 (2019): 23–43. http://dx.doi.org/10.1108/ijlss-01-2017-0003.
Full textO'Donovan, Orla. "Corporate Colonization of Health Activism? Irish Health Advocacy Organizations' Modes of Engagement with Pharmaceutical Corporations." International Journal of Health Services 37, no. 4 (2007): 711–33. http://dx.doi.org/10.2190/hs.37.4.h.
Full textDremova, N. B., and S. V. Solomka. "WORLD PHARMACEUTICAL MARKET: TRENDWATCHING." Laboratornaya i klinicheskaya meditsina. Farmatsiya, no. 3 (2022): 56–68. http://dx.doi.org/10.14489/lcmp.2022.01.pp.056-068.
Full textDolova, M. A., R. I. Yagudina, and N. I. Gavrilina. "Study of main factors that lead pharmaceutical workers to change their jobs." Remedium Journal about the Russian market of medicines and medical equipment, no. 9 (2020): 54–57. http://dx.doi.org/10.21518/1561-5936-2020-9-54-57.
Full textKang, So-Yeon, Ge Bai, Laura Karas, and Gerard F. Anderson. "Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context." American Journal of Public Health 109, no. 4 (2019): 559–61. http://dx.doi.org/10.2105/ajph.2018.304946.
Full textSteadman, Victoria A. "Drug Discovery: Collaborations between Contract Research Organizations and the Pharmaceutical Industry." ACS Medicinal Chemistry Letters 9, no. 7 (2018): 581–83. http://dx.doi.org/10.1021/acsmedchemlett.8b00236.
Full textBall, Christopher. "The role of contract research organizations in the new pharmaceutical industry." Pharmacological Research 31 (January 1995): 22. http://dx.doi.org/10.1016/1043-6618(95)86346-x.
Full textAlBrakat, Nour Salem Ahmad, Sulieman Ibraheem Shelash Al-Hawary, and Suhaib Mohammad Muflih. "The effect of green supply chain on the export performance of the Jordanian pharmaceutical industry." Uncertain Supply Chain Management 11, no. 2 (2023): 613–24. http://dx.doi.org/10.5267/j.uscm.2023.2.003.
Full textWageeh, A. Nafei. "The Role of Knowledge Management in Promoting Organizational Excellence: A Study on the Pharmaceutical Industry in Egypt." International Journal of Case Studies 5, no. 8 (2016): 125–43. https://doi.org/10.5281/zenodo.3531445.
Full textGusev, Alexander B., and Maksim A. Yurevich. "Economies of Scale in The Russian Pharmaceutical Industry: Empirical Assessments." Journal of Applied Economic Research 23, no. 4 (2024): 1055–76. https://doi.org/10.15826/vestnik.2024.23.4.041.
Full textIzmailov, Airat, Galina Astratova, and Arseny Ostrovsky. "Marketing Programs of Modern Pharmaceutical Enterprises." Economic Environment 13, no. 2 (2024): 79–87. http://dx.doi.org/10.36683/ee242.79-87.
Full textRonaghi, Mohammad Hossein, and Naeemeh Kamjoo. "Big Data and Pharmaceutical Industry: Applications and Priorities." Depiction of Health 14, no. 4 (2023): 441–50. http://dx.doi.org/10.34172/doh.2023.34.
Full textDurge, Mr Karan. "A Review: Regulatory Affairs in Pharmaceutical Industry." International Journal for Research in Applied Science and Engineering Technology 13, no. 5 (2025): 1028–32. https://doi.org/10.22214/ijraset.2025.70266.
Full textDoç., Dr. Neşe Mehmetoğlu Karakaş. "A Research On Turkish Medicines And Policies." urkish Journal of Healthy Aging Medicine (TJHAM) 1, no. 2 (2024): 1–16. https://doi.org/10.5281/zenodo.12744713.
Full textAlnidawi, Abdul Azeez Badir, and Fatimah Musa Omran. "Learning Organization Impact on Internal Intellectual Capital Risks: An Empirical Study in the Jordanian Pharmaceutical Industry Companies." International Business Research 9, no. 10 (2016): 176. http://dx.doi.org/10.5539/ibr.v9n10p176.
Full textVijay, Kotra. "Covid-19 Pandemic: Is it a Challenge or Opportunity for Pharmaceutical Industry around the Globe?" Pharmaceutics and Pharmacology Research 5, no. 7 (2022): 01–03. http://dx.doi.org/10.31579/2693-7247/089.
Full textLÖWY, ILANA. "‘Sexual chemistry’ before the Pill: science, industry and chemical contraceptives, 1920–1960." British Journal for the History of Science 44, no. 2 (2010): 245–74. http://dx.doi.org/10.1017/s0007087410000762.
Full textGolikova, Natalia S., and Nadezhda V. Prisyazhnaya. "Features of the modern human resources component of the pharmaceutical industry (based on the materials of a survey of employees of pharmaceutical and biotechnological companies and enterprises in Moscow)." Sociology of Medicine 21, no. 1 (2023): 117–26. http://dx.doi.org/10.17816/socm110877.
Full textRavi, Kiran Koppichetti. "Enterprise Data Lakes for Pharmaceutical Manufacturing: Enabling Digital Transformation in a Regulated Industry." Journal of Advances in Developmental Research 14, no. 1 (2023): 1–17. https://doi.org/10.5281/zenodo.14988366.
Full textRahman, Mostafizur, Sazali Abd Wahab, and Ahmad Shaharudin Abdul Latiff. "Organizational sustainability: Issues, challenges and the future of Bangladesh pharmaceutical industry." Journal of Future Sustainability 2, no. 4 (2022): 157–66. http://dx.doi.org/10.5267/j.jfs.2022.11.100.
Full textRahman, Mostafizur, Sazali Abd Wahab, and Ahmad Shaharudin Abdul Latiff. "Organizational sustainability: Issues, challenges and the future of Bangladesh pharmaceutical industry." Journal of Future Sustainability 2, no. 4 (2022): 157–66. http://dx.doi.org/10.5267/j.jfs.2022.11.001.
Full textRothman, Sheila M., Victoria H. Raveis, Anne Friedman, and David J. Rothman. "Health Advocacy Organizations and the Pharmaceutical Industry: An Analysis of Disclosure Practices." American Journal of Public Health 101, no. 4 (2011): 602–9. http://dx.doi.org/10.2105/ajph.2010.300027.
Full textOzieranski, Piotr, Marcell Csanadi, Emily Rickard, Jordan Tchilingirian, and Shai Mulinari. "Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015." JAMA Network Open 2, no. 6 (2019): e196253. http://dx.doi.org/10.1001/jamanetworkopen.2019.6253.
Full textKodynets, A. O., O. F. Doroshenko, I. P. Volynets, G. K. Dorozhko, V. O. Petrenko, and V. V. Belitsky. "Abuse of patent rights for pharmaceuticals in wartime conditions." Medicni perspektivi 29, no. 4 (2024): 237–46. https://doi.org/10.26641/2307-0404.2024.4.319395.
Full textKodynets, A.O., O.F. Doroshenko, I.P. Volynets, G.K. Dorozhko, V.O. Petrenko, and V.V. Belitsky. "Abuse of patent rights for pharmaceuticals in wartime conditions." Medicni perspektivi 29, no. 4 (2024): 237–46. https://doi.org/10.26641/2307-0404.2024.4.319395.
Full textGolikova, Nataliya Sergeevna, and Nadezhda Vladimirovna Prisyazhnaya. "Recommendations for conducting medical and sociological monitoring of the personnel needs of medical organizations on the example of studying the needs of regional pharmaceutical enterprises in pharmacists’ training (part 2*)." Glavvrač (Chief Medical Officer), no. 3 (February 20, 2022): 11–32. http://dx.doi.org/10.33920/med-03-2203-02.
Full textGolikova, Nataliya Sergeevna, and Nadezhda Vladimirovna Prisyazhnaya. "Recommendations for conducting medical and sociological monitoring of the personnel needs of medical organizations on the example of studying the needs of regional pharmaceutical enterprises in pharmacists’ training (part 1)." Glavvrač (Chief Medical Officer), no. 2 (January 20, 2022): 13–39. http://dx.doi.org/10.33920/med-03-2202-01.
Full textYaseen, Maysoon Mohammed, Rateb J. Sweis, Ayman Bahjat Abdallah, Bader Yousef Obeidat, and Nadia J. Sweis. "Benchmarking of TQM practices in the Jordanian pharmaceutical industry (a comparative study)." Benchmarking: An International Journal 25, no. 9 (2018): 4058–83. http://dx.doi.org/10.1108/bij-04-2017-0076.
Full textSattar, Muhammad Muzamil, Asad Ali Qazi, Farhan Shahzad, and Abdul Rehman Shaikh. "Flori Pharma: maintaining ethics in an unethical sales environment." Emerald Emerging Markets Case Studies 10, no. 1 (2020): 1–21. http://dx.doi.org/10.1108/eemcs-07-2019-0187.
Full textGautam, T. P. "Impact of HRM practices on Nepal's learning organizations." International Research Journal of Parroha (IRJP) 1, no. 1 (2025): 15–30. https://doi.org/10.5281/zenodo.15037221.
Full textWilliam Triplett. "Ransomware Attacks on the Healthcare Industry." Journal of Business, Technology and Leadership 4, no. 1 (2022): 1–13. http://dx.doi.org/10.54845/btljournal.v4i1.31.
Full textHaider, Rehan. "Innovation and Marketing in the Pharmaceutical Industry." Journal of Clinical Case Reports & Studies 5, no. 3 (2024): 01–09. http://dx.doi.org/10.31579/2690-8808/195.
Full textToda, Kenji. "Opportunities for Contract Research Organizations to Work with the Global Japanese Pharmaceutical Industry." Drug Information Journal 27, no. 4 (1993): 1137–39. http://dx.doi.org/10.1177/009286159302700430.
Full textPaluzzi, Joan E. "“Dualities of Interest”: The Inter-Organizational Relationships between Disease-Specific Nonprofits and the Pharmaceutical Industry." International Journal of Health Services 42, no. 2 (2012): 323–39. http://dx.doi.org/10.2190/hs.42.2.j.
Full textAli, Bakhtiyar, Muhammad Abu Bakr Ali, and Shameel Ahmed Zubairi. "The Impact of Salesforce Motivation on Organizational Performance in Pharmaceutical Industry of Karachi, Pakistan, 2019." International Journal of Industrial Marketing 5, no. 1 (2020): 34. http://dx.doi.org/10.5296/ijim.v5i1.17196.
Full textMurgoski, Tane. "Relationship between onboarding process and organizational culture in the pharmaceutical industry in North Macedonia." European Journal of Applied Economics 21, no. 1 (2024): 121–42. http://dx.doi.org/10.5937/ejae21-44834.
Full text